These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25066287)

  • 1. Night-time sedating H1 antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled study.
    Grattan C
    Br J Dermatol; 2014 Jul; 171(1):8-9. PubMed ID: 25066287
    [No Abstract]   [Full Text] [Related]  

  • 2. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial.
    Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA
    Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria.
    Wan KS
    J Dermatolog Treat; 2009; 20(4):194-7. PubMed ID: 19085267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilastine: a new H
    Church MK; Labeaga L
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):1447-1452. PubMed ID: 28467671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria.
    Boggs PB; Ellis CN; Grossman J; Washburne WF; Gupta AK; Ball R; Shulan D
    Ann Allergy; 1989 Dec; 63(6 Pt 2):616-20. PubMed ID: 2574555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined H1 and H2 antihistamine therapy in chronic urticaria.
    Monroe EW; Cohen SH; Kalbfleisch J; Schulz CI
    Arch Dermatol; 1981 Jul; 117(7):404-7. PubMed ID: 6114712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihistamines in urticaria and angioedema.
    Black AK; Greaves MW
    Clin Allergy Immunol; 2002; 17():249-86. PubMed ID: 12113219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
    dos Santos RV; Magerl M; Mlynek A; Lima HC
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):495-9. PubMed ID: 19558008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria.
    Sharma VK; Singh S; Ramam M; Kumawat M; Kumar R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):122-8. PubMed ID: 24685847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetirizine: a unique second-generation antihistamine for treatment of rhinitis and chronic urticaria.
    Pierson WE
    Clin Ther; 1991; 13(1):92-9. PubMed ID: 1674232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antihistamine up-dosing in chronic urticaria.
    Ferrer M; Sastre J; Jáuregui I; Dávila I; Montoro J; del Cuvillo A; Mullol J; Bartra J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():34-9. PubMed ID: 22185048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of acrivastine versus hydroxyzine and placebo in the treatment of chronic idiopathic urticaria.
    Salo OP; Harvey SG; Calthrop JG; Gibson JR
    J Int Med Res; 1989; 17 Suppl 2():18B-21B. PubMed ID: 2569996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis.
    Monroe EW
    Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
    Sussman G; Jancelewicz Z
    Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihistamine combination treatment for solar urticaria.
    Grundmann SA; Ständer S; Luger TA; Beissert S
    Br J Dermatol; 2008 Jun; 158(6):1384-6. PubMed ID: 18384474
    [No Abstract]   [Full Text] [Related]  

  • 17. Second-generation antihistamines for the treatment of chronic idiopathic urticaria.
    Belsito DV
    J Drugs Dermatol; 2010 May; 9(5):503-12. PubMed ID: 20480793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsedating H1 antihistamines in chronic urticaria.
    Monroe EW
    Ann Allergy; 1993 Dec; 71(6):585-91. PubMed ID: 7903515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of chronic spontaneous urticaria.
    Makris M; Maurer M; Zuberbier T
    Expert Opin Pharmacother; 2013 Dec; 14(18):2511-9. PubMed ID: 24195758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments.
    García-Gea C; Martínez-Colomer J; Antonijoan RM; Valiente R; Barbanoj MJ
    J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.